A 2015 Cochrane database evaluate identified inadequate proof to justify the use of G. lucidum as a primary-line cancer treatment.[5][six] It stated that G. lucidum could possibly have "benefit as an alternative adjunct to standard procedure in consideration of its possible of boosting tumour response and stimulating host immunity. Experiments https://ricardoamvlt.answerblogs.com/32663377/not-known-details-about-cordyceps